Advancing a ‘first-in-class’ monoclonal antibody to combat cancer.

Therapeutic Innovation Australia 2026 Open access

Read full text
Authors: Therapeutic Innovation Australia
DOI: 10.82292/bj7v-1986
Cited by: 0

Fields of Study & Subjects

Monoclonal and Polyclonal Antibodies Research Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses

Publication details

Journal / source
Therapeutic Innovation Australia
Publication date
17 February 2026
Language
EN